Re-irradiation for locally recurrent nasopharyngeal carcinoma

M McLean; E Chow; B O'Sullivan; A Munro; P M Leung; D A Loblaw; T Panzarella

doi:10.1016/s0167-8140(98)00052-8

Re-irradiation for locally recurrent nasopharyngeal carcinoma

Radiother Oncol. 1998 Aug;48(2):209-11. doi: 10.1016/s0167-8140(98)00052-8.

Authors

M McLean¹, E Chow, B O'Sullivan, A Munro, P M Leung, D A Loblaw, T Panzarella

Affiliation

¹ Department of Radiation Oncology, Princess Margaret Hospital/University of Toronto, Ontario, Canada.

PMID: 9783894
DOI: 10.1016/s0167-8140(98)00052-8

Abstract

Since 1989, 17 patients have undergone re-irradiation for locally recurrent nasopharyngeal cancer (NPC). The dose currently administered externally is 39.6 Gy in 36 fractions (BID) followed by an intracavitary boost (15-20 Gy). Disease persisted in five out of five patients treated palliatively. Eleven of 12 patients treated with curative intent achieved local control.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Brachytherapy / methods
Carcinoma / radiotherapy*
Cause of Death
Dose Fractionation, Radiation
Female
Follow-Up Studies
Humans
Male
Middle Aged
Nasopharyngeal Neoplasms / radiotherapy*
Neoplasm Recurrence, Local / radiotherapy*
Palliative Care
Radiotherapy Dosage
Radiotherapy, High-Energy
Survival Rate